Kodiak Sciences Inc. , a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat a broad spectrum of retinal diseases, announced today ...
Alphamab Oncology (Stock Code: 9966.HK) and CSPC Pharmaceutical Group Co., Ltd. ("CSPC") (Stock Code: 1093.HK) jointly announced that anti-HER2 biparatopic antibody-drug conjugate (ADC) JSKN003 has ...
The unique combination of high DAR and tailored therapeutic benefit offers potential for broad application to multifactorial diseases and builds directly from our Antibody Biopolymer Conjugate ...
Tubulis continues expansion of its clinical pipeline with a second ADC drug candidate entering the clinic TUB-030 is a next-generation ADC targeting 5T4 with an exatecan payload, developed ...
The antibody molecule KN026 is site-specifically modified via enzyme catalytic reaction and click chemistry to achieve a drug-to-antibody ratio (DAR) of approximately 4 ... an anti-HER2 bispecific ...
(“Innate” or the “Company”) will host an event for institutional investors and analysts dedicated to its Antibody-Drug Conjugate (ADC) strategy, and particularly Nectin-4, the target of ...
Riverwater Partners Sustainable Value Strategy highlighted stocks like Darling Ingredients Inc. (NYSE:DAR), in the fourth quarter 2024 investor letter. Darling Ingredients Inc. (NYSE:DAR ...
Ruprai are set to debut The Cloud Door, a new boutique label dedicated to bringing South Asian cinema to global audiences, with Kamal Swaroop’s influential cult film “Om Dar-B-Dar” (1988 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback